Neoantigen vaccine: an emerging tumor immunotherapy.

Peng M, Mo Y, Wang Y, Wu P, Zhang Y, Xiong F, Guo C, Wu X, Li Y, Li X, Li G, Xiong W, Zeng Z. · 2019

Read Neoantigen vaccine: an emerging tumor immunotherapy. by Peng M, Mo Y, Wang Y, Wu P, Zhang Y, Xiong F, Guo C, Wu X, Li Y, Li X, Li G, Xiong W, Zeng Z. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6708248.txt.

Description

Peng and co-authors review neoantigen vaccines, a new form of cancer treatment. Neoantigens are proteins made only by tumor cells, never by healthy tissue. They arise from the many mutations that build up in cancer cells. Because they look foreign, the immune system can be trained to attack them.

The review covers how computer tools find neoantigens from tumor DNA. It then surveys vaccine types, from nucleic acid and peptide shots to cell-based ones. Early trials suggest the vaccines are safe and can work. Pairing them with checkpoint drugs or radiation may work even better, the authors argue.

Catalog record

CREATORPeng M, Mo Y, Wang Y, Wu P, Zhang Y, Xiong F, Guo C, Wu X, Li Y, Li X, Li G, Xiong W, Zeng Z.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE73 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6708248

Browse the full library · About the Tower of Babel